Your browser doesn't support javascript.
loading
Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescents.
Riggenbach, Marguerite M; Haralambieva, Iana H; Ovsyannikova, Inna G; Schaid, Daniel J; Poland, Gregory A; Kennedy, Richard B.
Afiliação
  • Riggenbach MM; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
  • Haralambieva IH; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
  • Ovsyannikova IG; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
  • Schaid DJ; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Poland GA; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
  • Kennedy RB; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA. Electronic address: kennedy.rick@mayo.edu.
Clin Immunol ; 234: 108912, 2022 01.
Article em En | MEDLINE | ID: mdl-34968746
ABSTRACT
Despite high levels of MMR-II usage in the US, mumps outbreaks continue to occur. Evidence suggests that mumps vaccine-induced humoral immunity wanes over time. Relatively few studies have examined cell-mediated immunity or reported on sex-based differences. To better understand sex-based differences in the immune response to mumps vaccine, we measured neutralizing antibody titers and mumps-specific cytokine/chemokine responses in a cohort of 748 adolescents and young adults after two doses of MMR vaccine. We observed significantly higher neutralizing antibody titers in females than in males (120.8 IU/mL, 98.7 IU/mL, p = 0.038) but significantly higher secretion levels of MIP-1α, MIP-1ß, TNFα, IL-6, IFNγ, and IL-1ß in males compared to females. These data demonstrate that sex influences mumps-specific humoral and cell-mediated immune response outcomes, a phenomenon that should be considered during efforts to improve vaccines and prevent future outbreaks.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinação / Vacina contra Sarampo-Caxumba-Rubéola / Anticorpos Antivirais / Vírus da Caxumba Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Clin Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinação / Vacina contra Sarampo-Caxumba-Rubéola / Anticorpos Antivirais / Vírus da Caxumba Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Clin Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos